NCT04616976已完成不适用
Efficiency of Convalescent Plasma Therapy in Management of Critically Ill Patients With COVID-19: a Matched Case-control Study
Southeast University, China1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2020年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 78
- 试验地点
- 1
- 主要终点
- 28-day mortality
研究概览
简要总结
To clarify the effects of convalescent plasma therapy on SARS-CoV-2 negative conversion rate during hospital stay and 28-day mortality of severe and life-threatening COVID-19 patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •> 18 years of age;
- •laboratory-confirmed diagnosis of COVID-19;
- •respiratory failure requiring advanced respiratory support (i.e. high flow nasal cannula[HFNC], noninvasive mechanical ventilation [NIV], and invasive mechanical ventilation [IMV]).
排除标准
- 未提供
结局指标
主要结局
28-day mortality
时间窗: 28 days
the mortality from ICU admission to 28 days after admission
次要结局
- SARS-CoV-2 negative conversion rate(up to 60 days)
研究者
Chun Pan
Dr
Southeast University, China
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patientsIRCT20200406046968N2Tabriz University of Medical Sciences30
进行中（未招募）
不适用
Effectiveness and safety of plasma convalescent therapy in patients with COVID-19ISRCTN16842454Ministry of Research and Technology/National Research and Innovation Agency (Kementerian Riset dan Teknologi Republik Indonesia)5
已完成
2 期
Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19COVID-19NCT04438057Metro Infectious Disease Consultants103
终止
3 期
VA CoronavirUs Research and Efficacy Studies-1COVID-19NCT04539275VA Office of Research and Development75
已完成
2 期
Convalescent Plasma to Stem Coronavirus (CSSC-001)CoronavirusConvalescenceNCT04323800Johns Hopkins University180